Home News Issues My AVMA Jobs Animal Health Public Health AVMA@Work
Search Tips | Advanced Search
  
Search within Issues only.

AVMA's message to...

AVMA Member area AVMA members



FDA


About compounding

"Veterinary Compounding" brochure



Compounding FAQs



Pharmacology basics



What are the rules?



Definitions



AVMA policies



On the horizon



Related JAVMA News



FDA outreach

 

AVMA Member area = AVMA/SAVMA  Members Only


Get Adobe reader

Some files on this page require Adobe Reader software. Click on the image above to download it for free from the Adobe site.

 





 

FDA outreach to veterinarians and pharmacies

Veterinarians have the duty to utilize a compounded drug only when there is no approved animal drug or human drug that can adequately treat the condition, when either used as labeled or in an extralabel manner in its available dosage form and concentration. When there is an FDA-approved product available for adequate medical treatment, the active ingredient should not be compounded from a bulk substance.

Phenylbutazone in Horses Letter - Veterinarians (FDA Web site)

Vetoryl (trilostane) Capsules Letter - Pharmacists (PDF)

Vetoryl (trilostane) Capsules Letter - Veterinarians (PDF)

 

American Veterinary Medical Association
Copyright © 2009